<?xml version="1.0" encoding="UTF-8"?>
<p>While the VMMC trials that underpinned the global recommendations for VMMC as a key HIV prevention strategy had evaluated protective effects on men only, later evaluations have demonstrated additional direct protective benefits for female partners of circumcised men. A modeling study of Zimbabwe and Kenya estimated that VMMC reduces the rate of male-to-female HIV transmission by 46% from two years after the procedure, in addition to the 60% reduction in the female-to-male rate [
 <xref rid="pone.0199453.ref017" ref-type="bibr">17</xref>]. When we add a 46% protection against male-to-female transmission, the impact in terms of infections averted is 68% higher, and cost-effectiveness about 50% better, than in the default results (
 <xref rid="pone.0199453.t004" ref-type="table">Table 4</xref>).
</p>
